AbCellera Biologics Inc (ABCL) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

AbCellera Biologics Inc. - ABCL emitenti grafik logotipi

GURU.Markets platformasidagi AbCellera Biologics (ABCL) kompaniyasining ushbu kunlik narxlar grafigi mustaqillikni ta'minlash uchun o'zining Kanadadagi antitanachalar ishlab chiqarish quvvatlarini yaratayotgan kompaniya dinamikasini aks ettiradi. Immunologiya va AI texnologiyalaridagi yetakchiligi bozorning eng yirik ishtirokchilarini jalb qilmoqda. Joriy ko'rsatkich 0.14 darajasida turibdi, biznes esa barqaror royalti to'lovlariga tayanadi va uzoq muddatli rivojlanish sikllari allaqachon narxga kiritilgan.

AbCellera Biologics (ABCL): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

AbCellera Biologics Inc (ABCL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi AbCellera|ABCL - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati AbCellera Biologics Inc.|ABCL - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati AbCellera|ABCL - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati abcellera.com|ABCL - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati AbCellera Corp|ABCL - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati AbCellera Biologics Inc.|ABCL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi AbCellera|Tezkor likvidlik ko‘rsatkichi abcellera.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ABCL - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:AbCellera Biologics - ABCL
AbCellera Biologics Inc brend mahsuloti

Ushbu ko'rsatkich uzoq muddatli majburiyatlarning kapitalga nisbatini aniqlab, moliyaviy leveraj darajasini va balans hisoboti tuzilmasining tashqi zarbalarga chidamliligini o'lchaydi. Kapitaldagi uzoq muddatli qarz yuklamasini tahlil qilish orqali, investor AbCellera Biologics (ABCL) kompaniyasining o'z AI platformasi rivojlantirilishini moliyalashtirish va qarz mablag'lariga kritik bog'lanib qolmagan holda FDA talablariga muvofiqlikni saqlash qobiliyatini baholaydi, bu esa uzoq davom etadigan konsolidatsiya davrida bankrotlik xavfini minimallashtiradi.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|SVRA - Uzoq muddatli qarzning kapitalga nisbati|RIGL: Uzoq muddatli qarzning kapitalga nisbati|ANAB (anaptysbio.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Holdings Inc (ENGN)|Uzoq muddatli qarzning kapitalga nisbati RAPT|JBIO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|kyvernatx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA: Uzoq muddatli qarzning o'z kapitaliga nisbati|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Theratechnologies, Inc (THTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AGEN|Uzoq muddatli qarzning kapitalga nisbati Climb Bio Inc. (CLYM)|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATYR|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|IMA: Uzoq muddatli qarzning o'z kapitaliga nisbati|STTK: Uzoq muddatli qarzning kapitalga nisbati|EQ - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|Uzoq muddatli majburiyatlarning kapitalga nisbati Immunic Inc IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|Uzoq muddatli qarzning o'z kapitaliga nisbati IFRX (inflarx.de)|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|Adicet Bio Inc. (ACET) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati INmune Bio Corporation (INMB)|BRNS: Uzoq muddatli qarzning kapitalga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics PLC (AKTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM: Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|ADTX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed Therapeutics (AFMD)|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati